NCCN Adds Epcoritamab to Clinical Practice Guidelines in Oncology for DLBCL
Epcoritamab has been added to the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for B-cell Lymphomas in the third- or later-line setting for the treatment of patients with diffuse large B-cell lymphoma.
Navigating DLBCL Treatment Strategies for Patients Experiencing Resistance to Therapy
In his closing thoughts, Dr Gordon discusses navigation of treatment resistance in DLBCL management.
Additional Treatment Strategies and Collaborative Care for Patients with DLBCL
The impact of collaborative care in DLBCL treatment is explored by a medical expert.
2 Clarke Drive Cranbury, NJ 08512